Literature DB >> 9472677

Splenic T helper cell type 1 cytokine profile and extramedullary haematopoiesis in severe combined immunodeficient (scid) mice with inflammatory bowel disease (IBD).

S Bregenholt1, M H Claesson.   

Abstract

Scid mice develop a severe, chronic, and lethal IBD 3-6 months after engraftment of gut wall from immunocompetent congenic donors, induced by donor-derived CD4+ T cells migrating from the graft. We have investigated intracellular T-helper type 1 (Th1) cytokines in the spleens of gut wall-transplanted scid mice with IBD. Increased fractions of interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha) and IL-2-positive CD4+ T cells were found in the spleens of diseased mice compared with control mice. Moreover, a small but significant population of CD4+ T cells which stained positive for granulocyte-macrophage colony-stimulating factor (GM-CSF) was found in scid mice with IBD but was virtually absent in congenic non-scid control mice. Cloning of granulocyte/ macrophage colony-forming cells (G/M-CFC) revealed that both non-transplanted scid mice and scid mice with IBD had an 8-14-fold increase in splenic G/M-CFC compared with control mice. No significant difference in the number of G/M-CFC per total spleen was found between non-transplanted and disease scid mice, although both groups of mice showed a nearly two-fold increase compared with control mice. G/M-CFC were never found in the thymus, liver or lymph nodes of diseased mice. Immunohistochemistry revealed that the multinucleated giant cells observed in the gut wall of diseased mice did not represent haematopoietic foci, but were derived from macrophages. These observations point towards a dominant role for Th1-type CD4+ T cells in the immunopathogenesis of IBD, whereas haematopoiesis does not seem to be affected by the development of the disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9472677      PMCID: PMC1904855          DOI: 10.1046/j.1365-2249.1998.00459.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

1.  Macrophage activity in inflammatory bowel disease.

Authors:  Y R Mahida; D P Jewell
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

Review 2.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

Review 3.  Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse.

Authors:  G J Bancroft; R D Schreiber; E R Unanue
Journal:  Immunol Rev       Date:  1991-12       Impact factor: 12.988

Review 4.  Selective reconstitution of T lymphocyte subsets in scid mice.

Authors:  J Reimann; A Rudolphi; M H Claesson
Journal:  Immunol Rev       Date:  1991-12       Impact factor: 12.988

Review 5.  Single cell analyses of cytokine production.

Authors:  L L Carter; S L Swain
Journal:  Curr Opin Immunol       Date:  1997-04       Impact factor: 7.486

6.  Autoreactive natural killer-like cells from agar-cloned murine bone marrow cells.

Authors:  M H Claësson; L Olsson
Journal:  Nature       Date:  1980-02-07       Impact factor: 49.962

7.  A severe combined immunodeficiency mutation in the mouse.

Authors:  G C Bosma; R P Custer; M J Bosma
Journal:  Nature       Date:  1983-02-10       Impact factor: 49.962

Review 8.  The SCID mouse mutant: definition, characterization, and potential uses.

Authors:  M J Bosma; A M Carroll
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

9.  Chemotactic activity of human recombinant granulocyte-macrophage colony-stimulating factor.

Authors:  J M Wang; S Colella; P Allavena; A Mantovani
Journal:  Immunology       Date:  1987-03       Impact factor: 7.397

10.  Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor.

Authors:  R Munker; J Gasson; M Ogawa; H P Koeffler
Journal:  Nature       Date:  1986 Sep 4-10       Impact factor: 49.962

View more
  6 in total

1.  Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis.

Authors:  M Carlson; Y Raab; L Sevéus; S Xu; R Hällgren; P Venge
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

2.  In vitro activated CD4+ T cells from interferon-gamma (IFN-gamma)-deficient mice induce intestinal inflammation in immunodeficient hosts.

Authors:  S Bregenholt; J Brimnes; M H Nissen; M H Claesson
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

Review 3.  Stroke and T-cells.

Authors:  Thiruma V Arumugam; D Neil Granger; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

4.  Galectin-3 suppresses mucosal inflammation and reduces disease severity in experimental colitis.

Authors:  Hwei-Fang Tsai; Chien-Sheng Wu; Yi-Lin Chen; Hsiu-Jung Liao; I-Tsu Chyuan; Ping-Ning Hsu
Journal:  J Mol Med (Berl)       Date:  2015-12-02       Impact factor: 4.599

5.  Accumulation of immunoglobulin-containing cells in the gut mucosa and presence of faecal immunoglobulin in severe combined immunodeficient (scid) mice with T cell-induced inflammatory bowel disease (IBD).

Authors:  S Bregenholt; J Brimnes; J Reimann; M H Claesson
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

6.  Potent CCR3 Receptor Antagonist, SB328437, Suppresses Colonic Eosinophil Chemotaxis and Inflammation in the Winnie Murine Model of Spontaneous Chronic Colitis.

Authors:  Rhiannon T Filippone; Narges Dargahi; Rajaraman Eri; Jose A Uranga; Joel C Bornstein; Vasso Apostolopoulos; Kulmira Nurgali
Journal:  Int J Mol Sci       Date:  2022-07-14       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.